Navigation Links
Protox Announces Publication in Journal of the National Cancer,Institute Supporting PRX302 as Treatment for Prostatic Diseases

ucted by Dr Arthur Frankel and his team at the Cancer Research Institute of Scott and White Memorial Hospital in collaboration with scientists at Protox and Johns Hopkins University. Key findings include: human prostate cancer cells are significantly more sensitive to PRX302 in the presence of active PSA; PRX302 was totally resistant to thrombin, matrix metalloprotease 7 (MMP-7), human kallikrein 1 (hk1) and human kallikrein 2 (hk2) activation; and among the normal cells tested, the PSA-producing prostate epithelial cells were the only normal cells that were highly sensitive to PRX302.

Both publications demonstrated that the PSA-activated strategy for PRX302 has a number of inherent advantages as a therapeutic strategy for locally recurrent prostate cancer and BPH.

About Protox

Protox Therapeutics is a leader in advancing novel, targeted protein toxin therapeutics for treatment of cancer and other proliferative diseases. The company is actively developing two distinct but complementary platforms, INxin(TM) and PORxin, and currently has three clinical programs in
development. A Phase IIa clinical trial into the use of PRX321 (INxin) for the treatment of primary brain cancer has been completed and the drug has received Fast Track Designation and Orphan Drug Status from the US FDA. In addition, a Phase I trial has been completed for PRX321 to treat patients with renal cell carcinoma and non-small cell lung cancer. Patient enrolment is underway for a Phase I clinical study into the use of PRX302 (PORxin) to treat localized prostate cancer. PRX302 has also been approved by Health Canada to commence a Phase I clinical study for the treatment of benign prostatic hyperplasia.

NO REGULATORY AUTHORITY HAS APPROVED OR DISAPPROVED THE CONTENT OF THIS RELEASE. THE TSX VENTURE EXCHANGE DOES NOT ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

Certain st
'"/>




Page: 1 2 3

Related medicine technology :

1. Protox Announces Positive Clinical Data from Prostate Cancer Study
2. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
3. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
6. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
7. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
8. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
9. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
10. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
11. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
Post Your Comments:
(Date:5/21/2015)... Mass. , May 21, 2015  (MUSE ... the Electronic Health Record (EHR) is invaluable in ... Though EHRs are now a requirement and mainstream ... and continuously into the EHR is gaining traction ... Exchange), William Holmes, RN, Site Project Manager & ...
(Date:5/21/2015)... 21, 2015 ... Zwecks Leistungsvergleich zur Expertise und zum ... verwiesen, in denen uneingeschränkt betriebsfähige Systeme, ... ein Aegate-Land: beispielsweise BELGIEN   ... von Arzneimittelfälschungen (FMD) handelt es sich ...
(Date:5/21/2015)... 21, 2015  Today, eight groups representing ... biologics – Alliance for Patient Access, American ... Rheumatology, Biologics Prescribers Collaborative, Clinical Immunology Society, ... and North American Society for Pediatric Gastroenterology, ... to U.S. Food and Drug Administration (FDA) ...
Breaking Medicine Technology:Hospital Streamlines ICU Efficiency with Timely Data Integration 2Hospital Streamlines ICU Efficiency with Timely Data Integration 3EU-Arzneimittel-Richtlinie für gefälschte Medikamente; Aegate-Zusammenfassung als reale Bewertung aus Belgien 2EU-Arzneimittel-Richtlinie für gefälschte Medikamente; Aegate-Zusammenfassung als reale Bewertung aus Belgien 3Physician Groups Urge FDA to Ensure Patient Safety With Greater Transparency in Biosimilar Labeling 2Physician Groups Urge FDA to Ensure Patient Safety With Greater Transparency in Biosimilar Labeling 3Physician Groups Urge FDA to Ensure Patient Safety With Greater Transparency in Biosimilar Labeling 4
... at the 12th Congress of European Hematology,Association ... /PRNewswire-FirstCall/ --,Immunomedics, Inc. , a biopharmaceutical company ... and other serious,diseases, today announced that data ... Vienna, Austria, showed positive responses in patients,with ...
... Life Weight Loss and "Motivational Reserve" May Also ... -- A new study,suggests that treating risk factors ... pressure and diabetes, may slow the progression,of Alzheimer's ... Alzheimer's Association International Conference on Prevention,of Dementia in ...
Cached Medicine Technology:Fractionated Radioimmunotherapy With (90)Y-epratuzumab in,Non-Hodgkin's Lymphoma Appears Safe and Active in a Phase I/II,Study 2Fractionated Radioimmunotherapy With (90)Y-epratuzumab in,Non-Hodgkin's Lymphoma Appears Safe and Active in a Phase I/II,Study 3Fractionated Radioimmunotherapy With (90)Y-epratuzumab in,Non-Hodgkin's Lymphoma Appears Safe and Active in a Phase I/II,Study 4Fractionated Radioimmunotherapy With (90)Y-epratuzumab in,Non-Hodgkin's Lymphoma Appears Safe and Active in a Phase I/II,Study 5Treating Heart Disease Risk Factors May Slow Alzheimer's Disease,Progression 2Treating Heart Disease Risk Factors May Slow Alzheimer's Disease,Progression 3Treating Heart Disease Risk Factors May Slow Alzheimer's Disease,Progression 4Treating Heart Disease Risk Factors May Slow Alzheimer's Disease,Progression 5Treating Heart Disease Risk Factors May Slow Alzheimer's Disease,Progression 6Treating Heart Disease Risk Factors May Slow Alzheimer's Disease,Progression 7
(Date:5/22/2015)... Boca Raton, FL (PRWEB) May 22, 2015 ... organization which provides vascular, electrocardiogram (EKG), echocardiogram and ... of David Sempier, a highly respected All American National ... a multi-sport athlete, I find the high level of ... to both the athlete and their athletic trainers, this ...
(Date:5/22/2015)... 2015 In April 2006, Veatch Consulting ... 9 years they have concentrated their focus to working ... Canada. Because of this growth and their goals to ... in Denver, Colorado, Cleveland, Ohio, Houston, Texas and now ... new dental offices, dental start ups, orthodontic practices, pediatric ...
(Date:5/22/2015)... 2015 In efforts to offer full ... containing particular muscles stretches has been a large focus ... stretches now complete, Chunk Fitness envisions a mid-June launch ... filmed and released at a later point in time. ... http://www.chunkfitness.com/stretches . , About the Company: Chunk Fitness ...
(Date:5/21/2015)... May 21, 2015 World Patent Marketing, ... launches the Troll Motor Guide, a boat patent that ... , "The recreational boating industry has reached an annual ... and Creative Director of World Patent Marketing , ... and predicts continued steady growth of seven percent in ...
(Date:5/21/2015)... (PRWEB) May 21, 2015 Ticket Down is a ... featuring USA vs. Guatemala on Friday, July 3rd at ... now to become a fan of international soccer. The number of ... play on American soil is growing at a large clip. Over ... have come to the USA to play in front of the ...
Breaking Medicine News(10 mins):Health News:Wimbledon Athletics Recruits Team USA Athlete 2Health News:Wimbledon Athletics Recruits Team USA Athlete 3Health News:Great Ways To Celebrate On Memorial Day Weekend- Starting With World Patent Marketing's New Boat Patent 2Health News:Great Ways To Celebrate On Memorial Day Weekend- Starting With World Patent Marketing's New Boat Patent 3Health News:USA vs. Guatemala Tickets: Ticket Down Slashes United States Men's Soccer Team (USMNT) vs. Guatemala Tickets at LP Field in Nashville on 7/3/15 2
... laws have been enacted to protect minors from sexual abuse ... activity before the legal age of consent and are facing ... Institute at Sam Houston State University examines various state ... and suggests ways to address the dilemmas caused by the ...
... professor of psychology in the School of Science at ... for Aging Research affiliated scientist, has received a $110,000 ... treatment of depression before one experiences a heart attack ... The research study, Beating the Blues for Your ...
... been in use for more than 30 years, but have ... to research supporting the benefits of EMRs and federal legislation. ... is a need for additional research of how the system ... Brigham and Women,s Hospital have done just that, and discovered ...
... of iodine using a microwave, has been discovered by an ... produced by fission of uranium fuel in a nuclear reactor. ... mobile in the environment and selective uptake by the thyroid ... exposure. Furthermore, iodine-129, which is a type of radioactive iodine, ...
... men in Japan, the presence of fatty liver disease ... with the frequency of moderate alcohol consumption; however, there ... disease with higher volume of alcohol consumed per day. ... did non-drinkers, and both obesity and metabolic abnormalities were ...
... By Amanda Gardner HealthDay Reporter , MONDAY, May ... wasteful imaging for lower back pain and foregoing annual ECG ... could help streamline primary care, experts say. Perhaps taking ... of a new report came up with a "Top 5" ...
Cached Medicine News:Health News:Crime Victims' Institute studies adolescent sex and laws 2Health News:IUPUI study first to look at early treatment of depression to reduce heart disease risk 2Health News:Expert discovers simple method of dealing with harmful radioactive iodine 2Health News:Experts Issue 'Top 5' List for Better Primary Care 2Health News:Experts Issue 'Top 5' List for Better Primary Care 3
... 105SL is the newest member ... and its also the fastest, ... capacity with rugged and reliable ... proven platform, the 105SL is ...
... The Transfusion Safety Management system ensures your ... and care. , BloodTrack SafeTx uses the ... patient from sample collection to transfusion. SafeTx ... and reduces the need for bedside paperwork ...
... Cerner point-of-care solution, is a bar-code-enabled ... The solution enhances the safety and ... by employing bar-code scanning technology, wireless ... to prevent potential patient identification and ...
wCareMed™ utilizes barcode scanning technology to support medication administration. It is a simple to use point of care application that provides access to patient information on a lightweight,...
Medicine Products: